Back to EZorb Newsletter Index

In this issue:

1. Share Success: Letters From Readers
2. Research News: Psychologic Wellbeing During Lockdown May Affect Type 2 Diabetes Glucose Control
3. Useful Links
4. What Are Others Saying About EZorb and Marvlix?

Letter I: From Anna S.
Received at Testimonial Submit Form Saturday, March 27, 2021 at 09:46:17
(Unedited)

Hi, my name is Anna Sophia and I have been taking both products for almost a year.

I am not a person who writes reviews but I LOVE both of these products so I wanted to share how they have helped me.

I am 58 and very healthy until I went for a physical and was told I had early signs of Osteoporosis. I did my research and started taking EZorb Calcium Aspartate Anhydrous 4 capsules twice a day and notice a different in the way my body felt, specially when doing my stretching in the morning. My back used to crack and now it doesn't and I have less pain.

Love it so much I decided to try the Marvlix and was definitely pleased. I have always had some stomach issues and since taking 4 capsules a day of Marvlix it has gone away.

Besides being such an amazing product customer service is just as good and very helpful! I highly recommend EZorb and Marvlix!

Letter II: From Mark B.
Recorded at Testimonial Submit Form Thursday, March 04, 2021 at 12:06:34
(Unedited)

Hi, I am an EZorb customer that had positive results removing Heel Bone Spurs using EZorb powder.

Taking one dose a day, my heel spur pain was gone in 3 months and have not returned.

I gave a bottle to my 80 year old Aunt for her arthritis pain. After one month at only taking the maintenance dose, (she is on a fixed low income) she could not believe how much better she feels and she bought her second bottle.

I wanted to share your testimonial page to my elderly sister in laws but could not find a share option. Therefore, can you share this email to them? sunshinebuddiesxx@xxx.xxx Thanks.

This newsletter is now read by over 120,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's life.

Please email your story to sharesuccess @ ezorbonline.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.

COVID-19 restrictions do not significantly impact glycated hemoglobin (HbA1c) levels in individuals with type 2 diabetes, but those with poor psychologic wellbeing may experience worsening glycemic control, suggest findings from an Italian study.

The researchers compared data from 141 adults (median age 68 years) attending one of three diabetes centers during a COVID-19 lockdown period who did not require intensification of their usual diabetes therapy, and 123 control individuals with type 2 diabetes (median age 69 years) who attended the study centers 1 year previously.

The median disease duration in both groups was 13 years and 61% were men. For the lockdown group, baseline data were collected from December 2019 to March 2020, and follow-up data from June to July 2020. For the control group, the researchers used the same time frames in 2018-2019.

As reported in Diabetes, Obesity and Metabolism, median HbA1c levels decreased by 0.1% from baseline to follow-up in both the lockdown and the control groups, and there was no significant difference in HbA1c levels at follow-up, at 7.3% (56 mmol/mol) versus 7.4% (57 mmol/mol).

BMI remained consistent in the lockdown and control groups during the study period, with median baseline values of 28.2 and 26.2 kg/m2, respectively. There were also statistically comparable decreases in glucose (6.0 vs 0.0 mg/dL) and high-density lipoprotein cholesterol (1.0 vs 2.0 mg/dL) from baseline to follow-up.

In a subgroup analysis, the investigators looked at changes in HbA1c and BMI among people in the lockdown group with different degrees of psychologic wellbeing, assessed by the Psychological General Well-Being Index (PGWBS). They found that people in the lowest tertile for PGWBS score, indicating worse psychologic health, experienced worsening HbA1c and BMI during follow-up, whereas those in the highest tertile did not.

“This evidence suggests that patients with diabetes are at increased risk of mental issues related to the pandemic, which then may translate into a significant worsening of metabolic control, calling for health care systems to consider special psychological support for this category,” conclude the investigators.

Original research was published in Diabetes Obes Metab 2021; doi:10.1111/dom.14380.

EZorb - Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index